EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Oral Food Challenges After Treatment With Omalizumab in the Clinical Setting

Hao Tseng, Robert A Wood, Jackie Isola, Nicholas Anania, Jennifer Dantzer

The Journal of Allergy and Clinical Immunology: In Practice · 2026-05 · 14 (5) · 1142-1152.e2

DOI: 10.1016/j.jaip.2026.02.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-05. Verfasst von Hao Tseng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Allergy, Immunology, and Rheumatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. Hauptthemen laut MEDLINE: Omalizumab, Anti-Allergic Agents, Food Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Food Allergy Research and Education, Doris Duke Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmalizumabAnti-Allergic AgentsFood HypersensitivityHumansFemaleChildImmunoglobulin EMaleRetrospective StudiesInfantAdolescentChild, PreschoolAllergensYoung AdultAdministration, OralTreatment Outcome

Stichwörter der Autor:innen

Anti-IgEFood allergyOmalizumabOral food challengePredictors

Substanzen

OmalizumabAnti-Allergic AgentsImmunoglobulin EAllergens

Autor:innen und Institutionen

  • Division of Pediatric Allergy, Immunology, and Rheumatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md.
  • Division of Pediatric Allergy, Immunology, and Rheumatology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: jwrubel1@jhmi.edu.

Förderung

  • NIAID NIH HHS
  • Food Allergy Research and Education
  • Doris Duke Charitable Foundation
  • Genentech
  • Immune Tolerance Network
  • National Institute of Allergy and Infectious Diseases
  • Novartis

Zitieren

APA

Tseng, H., Wood, R. A., Isola, J., Anania, N., & Dantzer, J. (2026). Oral Food Challenges After Treatment With Omalizumab in the Clinical Setting. The Journal of Allergy and Clinical Immunology: In Practice, 14(5), 1142-1152.e2. https://doi.org/10.1016/j.jaip.2026.02.033

Vancouver

Tseng H, Wood RA, Isola J, Anania N, Dantzer J. Oral Food Challenges After Treatment With Omalizumab in the Clinical Setting. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(5):1142-1152.e2. doi:10.1016/j.jaip.2026.02.033

BibTeX
@article{Tseng2026,
  author = {Tseng, Hao and Wood, Robert A and Isola, Jackie and Anania, Nicholas and Dantzer, Jennifer},
  title = {Oral Food Challenges After Treatment With Omalizumab in the Clinical Setting},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {1142--1152.e2},
  doi = {10.1016/j.jaip.2026.02.033}
}
Kostenlos starten →